CORRELATION BETWEEN OBESITY AND THYROTROPIN (TSH) IN CLINICALLY EUTHYROID SUBJECTS.

Jameson JL, Weetman AP. Disorders of the thyroid gland. In: Fauci AS, Braunwald E, Kasper DL, et al. eds. Harrison’s Principles of Internal Medicine. Vol. 2. 17th edn. New York: The McGraw-Hill 2008: p. 2224-47.

Bastemir M, Akin F, Alkis E, et al. Obesity is associated with increased serum TSH level, independent of thyroid function. Swiss Med Wkly 2007;137(29-30):431-4.         

Sorisky A, Bell A, Gagnon A. TSH receptor in adipose cells. Horn Metab Res 2000;32(11-12):468-74.             

Schaffler A, Binart N, Scholmerich J, et al. Hypothesis paper Brain talks with fat -- evidence for a hypothalamic-pituitary-adipose axis? Neuropeptides 2005;39(4):363-7.                               

Rosenbaum M, Hirsch J, Murphy E, et al. Effects of changes in body weight on carbohydrate metabolism, catecholamine excretion and thyroid function. Am J Clin Nutr 2000;71(6):1421-32.                 

Valyasevi RW, Harteneck DA, Dutton CM, et al. Stimulation of adipogenesis, peroxisome proliferator-activated receptor gamma (PPARgamma) and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab 2002;87(5):2352-8.      

Rajala MW, Scherer PE. Minireview: the adipocyte -- at the crossroads of energy homeostasis, inflammation and atherosclerosis. Endocrinology 2003;144(9):3765-73.               

Rondinone CM. Adipocyte-derived hormones, cytokines and mediators. Endocrine 2006;29(1):81-90.          

Menendez C, Baldelli R, Camina JP, et al. TSH stimulates leptin secretion by a direct effect on adipocytes. J Endocrinol 2003;176(1):7-12.                

Zimmermann-Belsing T, Brabant G, Holst JJ, et al. Circulating leptin and thyroid dysfunction. Eur J Endocrinol 2003;149(4):257-71.       

Danese MD, Ladenson PW, Meinert CL, et al. Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of literature. J Clin Endocrinol Metab 2000;85(9):2993-3001.               

Visscher TLS, Seidell JC. The public health impact of obesity. Ann Rev Public Health 2001;22:355-75.          

Kundsen N, Laurberg P, Rasmussen LB, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 2005;90(7):4019-24.            

De Pergola G, Ciampolillo A, Paolotti S, et al. Free tri-iodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independent of insulin resistance, metabolic parametres and blood pressure in overweight and obese women. Clin Endocrinol (Oxf) 2007;67(2):265-9.               

Jung CH, Sung KC, Shin HS, et al. Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP and waist hip ratio in Korea. Korean J Intern Med 2003;18(3):146-53.            

Kota SK, Meher LK, Jammula S, et al. Obesity and thyrotropinemia: association in Indian adults. Thyroid Research and Practice 2013;10(1):4-7.

Mahanta A, Choudhury B, Choudhury DS. Serum thyrotropin level in relation to obesity indicators in a clinically euthyroid population. International Journal of Physiology 2013;1:7-12.

Galofre JC, Pujante P, Abreu C, et al. Relationship between thyroid stimulating hormone and insulin in euthyroid obese men. Ann Nutr Metab 2008;53(3-4):188-94.      

Shon HS, Jung ED, Kim SH, et al. Free T4 is negatively correlated with body mass index in euthyroid women. Korean J Intern Med 2008;23(2):53-7.     

Harikumar KVS, Verma A, Muthukrishnan J, et al. Obesity and thyrotropinemia. Indian J Pediatrics 2009;76(9):933-5.               

Ambrosi B, Masserini B, Iorio L, et al. Relationship of thyroid function with body mass index and insulin resistance in euthyroid obese subjects. J Endocrinol Invest 2010;33(9):640-3.